An interventional study of Clamping and Non Clampling in Pneumothorax, Chest Tube and Pleural Diseases, sponsored by National Institute of Respiratory Diseases, Mexico. Completed at 1 site in Mexico. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2023-05-31.
Sponsored by National Institute of Respiratory Diseases, Mexico · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Through this randomized controlled clinical trial, we aim to identify whether there is a difference in the incidence of 24 hour pneumothorax after chest tube removal, in two blindly randomized groups of patients: The first group with chest tube clamping 6 hours prior to removal, and the second group there will be no chest tube clamping.
The data will be prospectively collected from patient records from the National Institute of Respiratory Diseases Ismael Cosío Villegas.
Patients with an indication of chest tube removal will be randomized to two possible arms: clamping (for 6 hours before removal) or not clamping (immediate removal).
Incidence of 24hour pneumothorax after chest tube removal will be recorded.
183 studies on the registry are indexed under Pneumothorax; 41 are open to participants now.
This study's enrollment of 93 is close to the median of 100 across 111 interventional studies indexed under Pneumothorax.
Browse Pneumothorax studies →National Institute of Respiratory Diseases, Mexico is the lead sponsor of 17 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with 6hour clamping prior to removal
Procedure: Clamping
Patients will have chest tube removed immediately
Procedure: Non Clampling
There will be a randomized selection of patients who will have a clamping of the chest tube 6 hours prior to chest tube removal.
There will be a randomized selection of patients who wont have chest tube clamping 6 hours prior to chest tube removal.
Incidence of pneumothorax after chest tube removal with chest tube clamping
Cases of pneumothorax after chest tube removal despite clamping
Time frame: After 24 hours of procedure
Incidence of pneumothorax after chest tube removal without chest tube clamping
Cases of pneumothorax after chest tube removal despite clamping
Time frame: After 24 hours of procedure
Hospital days of stay
Hospital days of stay
Time frame: Through study completion, an average of 1 month
Plan to share: Yes — Database will be available once the protocol is complete
Supporting information: Study protocol, Informed consent form, Clinical study report
Time frame: Once completed for one year
Access criteria: Free access
No publications or documents are linked to this record.
Ran from Dec 2021 to primary completion in Mar 2023, 15 months.
Of 41 non-industry interventional studies with no phase under Pneumothorax, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 34. This study's 15 months is below that.
Counting every sponsor, half of 43 studies reached it within 26 months; a quarter within 14 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Institute of Respiratory Diseases, Mexico